dosedrugsOnlineOfflineع
You're offline — running on data saved to your device.

gliptinmix 5/1000 mg 10 tablets

جلبتين ميكس 5/1000 مجم 10 اقراص

saxagliptin+metformin
Public price58.5EGP

The published official price. Pharmacies may differ slightly.

Strength
5/1000mg
Form
tablet
Manufacturer
organopharma
Route
oral.solid

The medical information below is guidance and may be incomplete or wrong. Do not change your medicine or dose based on it — ask a pharmacist or doctor.

Uses

A combination of saxagliptin (DPP-4 inhibitor) and metformin (biguanide) indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

Do not use if

Contraindicated in patients with severe renal impairment (eGFR below 30 mL/min/1.73 m²), acute or chronic metabolic acidosis including diabetic ketoacidosis, and history of serious hypersensitivity to saxagliptin or metformin.

Side effects

Common adverse reactions include upper respiratory tract infection, urinary tract infection, and nasopharyngitis. Serious risks include lactic acidosis (metformin), pancreatitis (saxagliptin), heart failure hospitalization, and hypoglycemia when combined with insulin secretagogues. Vitamin B12 deficiency may occur with long-term metformin use.

Warnings

Boxed warning: metformin-associated lactic acidosis can be fatal; risk increases with renal impairment, hepatic impairment, congestive heart failure, and excessive alcohol intake. Hold metformin before iodinated contrast procedures. Monitor renal function regularly. Saxagliptin has been associated with an increased risk of heart failure hospitalization.

How it works

Saxagliptin inhibits the enzyme DPP-4, thereby increasing active incretin hormone (GLP-1 and GIP) concentrations, which stimulate glucose-dependent insulin release and suppress glucagon. Metformin decreases hepatic glucose production, reduces intestinal glucose absorption, and improves peripheral insulin sensitivity.

Storage

Store at room temperature, 20°C to 25°C. Protect from moisture.